Thermo Fisher Scientific Dec 9, 2021 FDA Approves Thermo Fisher Scientific Oncomine Dx Assay as CDx for Janssen Lung Cancer Drug Nov 24, 2021 Local Cancer Genomic Profiling Options Grow, Though Central Labs Will Likely Keep Major Role Premium Sep 24, 2021 T Cell Repertoire Emerging as Potential Predictor in Neoadjuvant Lung Cancer Immunotherapy Premium Sep 16, 2021 FDA Approves Takeda's Exkivity With Thermo Fisher CDx for EGFR Exon20 Insertion-Positive NSCLC Sep 10, 2021 Japanese Health Ministry Clears Thermo Fisher Scientific Oncomine Assay as CDx for Lung Cancer Drug Sep 1, 2021 Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs Aug 26, 2021 FDA Clears Thermo Fisher Scientific Oncomine Assay as CDx for Bile Duct Cancer Drug Apr 29, 2021 TMB-High Status Does Not Predict Opdivo-Yervoy Response in Pan-Tumor Analysis Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Nov 17, 2020 Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition Sep 8, 2020 FDA Approves Thermo Fisher Scientific CDx for Genentech's Gavreto in NSCLC Patients With RET Fusions Aug 17, 2020 Thermo Fisher Scientific, Hengrui Therapeutics Ink CDx Deal for Pyrotinib in HER2-Mutated NSCLC Jul 8, 2020 Thermo Fisher Scientific, Chugai Pharmaceutical Sign Companion Diagnostic Agreement for NSCLC Jun 23, 2020 Thermo Fisher Scientific, Daiichi Sankyo Partner to Develop Non-Small Cell Lung Cancer CDx Jun 11, 2020 Thermo Fisher Scientific, Genetron Health Partner on NGS-Based Cancer Dx in China Jun 9, 2020 Thermo Fisher Scientific, Agios Pharmaceuticals to Codevelop Glioma Companion Diagnostic Apr 22, 2020 Bio-Me Awarded $2.2M to Develop Microbiome Biomarker Test for Cancer Immunotherapy Apr 19, 2020 Despite FDA Guidance, CDx Providers Still Have Challenges in Seeking 'Therapeutic Group' Indication Premium Mar 12, 2020 Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications Feb 13, 2020 Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
